---
title: "歌礼制药-B10 月 10 日斥资 98.24 万港元回购 10 万股"
description: "智通财经 APP 讯，歌礼制药-B 发布公告，于 2025 年 10 月 10 日，该公司斥资 98.24 万港元回购 10 万股股份，每股回购价格为 9.47-10.99 港元。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/260602142.md"
published_at: "2025-10-10T10:30:04.000Z"
---

# 歌礼制药-B10 月 10 日斥资 98.24 万港元回购 10 万股

> 智通财经 APP 讯，歌礼制药-B 发布公告，于 2025 年 10 月 10 日，该公司斥资 98.24 万港元回购 10 万股股份，每股回购价格为 9.47-10.99 港元。

智通财经 APP 讯，歌礼制药-B(01672) 发布公告，于 2025 年 10 月 10 日，该公司斥资 98.24 万港元回购 10 万股股份，每股回购价格为 9.47-10.99 港元。

### Related Stocks

- [01672.HK - 歌礼制药-B](https://longbridge.com/zh-CN/quote/01672.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| GIC Private Limited initiated a stake in Ascletis Pharmaby 64,128,000 shares at a price of HKD 12.18 per share | GIC Private Limited has acquired a stake in Ascletis Pharmaby purchasing 64,128,000 shares at HKD 12.18 each, totaling a | [Link](https://longbridge.com/zh-CN/news/275105288.md) |
| Ascletis Pharma Boosts Share Buyback Plan to HK$500 Million | Ascletis Pharma Boosts Share Buyback Plan to HK$500 Million | [Link](https://longbridge.com/zh-CN/news/269948463.md) |
| Al Waha Capital FY Dividend 10 Fils /Share | AL WAHA CAPITAL :FY DIVIDEND 10 FILS PER SHARE | [Link](https://longbridge.com/zh-CN/news/276031213.md) |
| GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets | GIC has invested approximately US$100 million in Ascletis Pharma (1672. HK) by acquiring 64,128,000 shares at an average | [Link](https://longbridge.com/zh-CN/news/275106794.md) |
| Ascletis Pharma to Raise HK$835 Million via Share Placement to Fund Obesity Drug Trials | Ascletis Pharma Inc. plans to raise approximately HK$835 million through a share placement of 69,256,000 new shares at H | [Link](https://longbridge.com/zh-CN/news/274573426.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。
